Abstract
Author(s): Harshal Ashok Pawar, Anjali Harshal Pawar, Sandip Ashok Pawar, Prashant Ashok Pawar
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). The disease was first identified in December 2019 in Wuhan, the capital of China's Hubei province, and has since spread globally, resulting in the ongoing 2019–20 coronavirus pandemic. The COVID?19 pandemic has placed incredible tension on healthcare systems around the globe. Common symptoms include fever, cough, and shortness of breath. Other symptoms may include muscle pain, diarrhea, sore throat, loss of smell, and abdominal pain. It is challenging for doctors and physicians to distinguish COVID?19 from other acute respiratory tract infections via clinical symptoms because those who are infected display a wide range of symptoms. An effective, point?of?care (POC) diagnostic tool could ease healthcare system strain, protect healthcare professionals, and support quarantine efforts. With a lack of effective medical treatments or vaccines for COVID-19, early identification and patient isolation has been the most effective means of disease management to slow the spread of the pandemic. COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or of antibodies produced in response to infection. Test analysis is often performed in automated, high-throughput, medical laboratories by medical laboratory scientists. In this article, we have discussed the currently used diagnostic tests for detection of Coronavirus and COVID?19.
